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Background: A syndemic conjoins injection drug use, incarceration, and HIV in Vietnam, where there is a need for
programs that empower people who use drugs to minimize the harms thereby produced. Here we present a
post-hoc evaluation of the organizing efforts of the Centre for Supporting Community Development Initiatives
(SCDI) with two community-based drug user groups (CBGs) in Hanoi.
Methods: Members (n = 188) of the CBGs were compared to non-member peers (n = 184) on demographic,
psychosocial, behavioral and knowledge variables using a face-to-face structured interview that focused on issues of
quality of life and harm reduction. Bivariate analyses were conducted, and variables significantly associated with
membership at p < 0.10 were included in a multivariate model.
Results: Variables associated with membership in the CBGs in the multivariate model included increased
self-efficacy to get drug-related health care (OR 1.59, 1.24-2.04), increased quality of life in the psychological
(OR 2.04, 1.07-3.93) and environmental (OR 2.54, 1.31-4.93) domains, and greater history of interactions with police
about drugs (OR 3.15, 1.79-5.52). There was little difference between members and non-members on
injection-related harms except in the domain of knowledge about opioid overdose. Among the 114 current
injectors (30.6% of the sample), low rates of unsafe injection practices were reported, and low statistical power
limited the ability to conclusively assess association with membership.
Conclusions: Although the CBG members displayed higher levels of well-being and access to healthcare than
non-members, further longitudinal study is required to determine if these are a result of membership. The CBGs
should pay more attention towards meeting challenges in responding to specific health issues of those who
continue to use drugs including HIV, hepatitis, and drug overdose.
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Quality of lifeIntroduction
In Vietnam, injection drug use and HIV are closely
linked, and the HIV epidemic is concentrated in injection
drug users (IDUs). Government documents report that
250,000 HIV cases have been reported through the end of
2011, there are an estimated 115,000-350,000 IDUs, and
HIV prevalence among the IDUs is 13.4% nationwide. As
many as 69% of incident cases occur in IDUs [1]. However,* Correspondence: robert.heimer@yale.edu
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distribution, and reproduction in any mediuminjection drug use has repercussions that extend well
beyond the risk of HIV. Mortality rates among male IDUs
are 13.4 times higher than the general male population
after indirect standardization. Though the leading cause
of death in IDUs was AIDS-related illness (31%), an
additional 27% were caused by overdoses [1,2]. Beyond
physical morbidity and mortality, drug use carries a
significant mental health burden; an estimated 22.4%
of opioid users in Vietnam have depression [3]. IDUs
also report high levels of stigma from their communities,
which are often amplified in the presence of HIV infectionentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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many cases places the burden of care on their families [4].
Vietnam is heavily influenced by Confucianism, which
holds that the self should be considered last and that
one should always devote one’s attention to the country
and the family first. Communism, which was introduced
into the country in the midst of harsh wars, echoed this
norm in order to unify the country and mobilize people.
People with addiction therefore have always been seen
in a negative light as self-indulged, selfish, and spoiled.
In addition, as evidence-based addiction treatment has
only been introduced very recently with the initiation
of methadone treatment programs (which so far have
covered less than 10% of people with drug addiction),
drug users need money to buy drugs, and they commit
crimes. Although most of the crimes committed by
drug users are petty crimes, they affect everyday life in
Vietnam and drug users are thus perceived as danger-
ous, creating public chaos and deserving of punishment.
Punitive measures therefore receive strong support from
both policy makers and the general public [5]. Even for
those drug users without HIV infection, the risks to their
liberty are great through an extrajudicial administration
system that can enforce mandatory incarceration for up to
four years based solely on positive drug test results [6,7].
These interconnected ills demonstrate that IDUs in
Vietnam are in need of comprehensive programs that
can increase their quality of life, create more social
support, and reduce their risks to health and safety.
These programs, which include but extend beyond
harm reduction, have not always been readily available.
Indeed, the development of comprehensive programs
designed to empower drug users is a relatively new
phenomenon. It originated in drug user groups and a
growing acceptance of a human rights framework that
viewed criminalization of drug use as abuse [8-11]. This
approach begins with the traditional individual-level
definition of harm reduction and broadens it to include
drug user empowerment as a development goal [12,13].
Historically, the government of Vietnam did not sup-
port harm reduction initiatives, and oversight of injec-
tion drug use policy fell to the Department of Social
Evils Prevention in the Ministry of Labor, Invalids, and
Social Affairs [14]. Drug users have often been sent to
government detoxification centers, called 06 centers,
where they could be incarcerated for up to four years at
a time [7,15]. However, the official policy environment
regarding injection drug use has shifted significantly in
the last seven to ten years. In 2006, after seeing inter-
national evidence of the benefits of harm reduction
programs, the Vietnamese government passed the Law
on HIV/AIDS Prevention and Control, which officially
sanctioned harm reduction programs including needle
syringe programs (NSPs) and methadone treatment[16]. While many government officials, international
partners, and community members say this revised policy
approach is a clear improvement, they note that there is
still conflict between drug control laws and HIV preven-
tion laws [7,15,16]. Since harm reduction was written into
the law in 2006, the government’s policy towards drug
users has changed significantly, most notably through the
decriminalization of drug use in the Amendment of Penal
Code 2009 and the Administration Sanction Law 2012
following which a drug user can only be sent to a com-
pulsory center by a duly constituted court. Currently, a
Renovation Plan on Drug Treatment is being reviewed
by the government, with approval possible as early as
the beginning of 2014. However, in efforts to maintain
“public order”, law enforcement tends to apply other
existing legislation to keep drug users off the streets.
While drug users are not supposed to be arrested for
using drugs, they can still be arrested for possession of
drugs or organizing drug use if more than one person is
caught using at the same place. Until the Renovation
Plan is approved, there are still more than 100 compulsory
centers in the country and many drug users are still sent
there.
High-level policy change does not always result in
change on the ground. As many as 50,000 IDUs (25% of
all IDUs) were in 06 centers in 2007, despite the fact that
users who are sent to such centers have drug relapse
rates of between 80 and 90% [15,17]. Scale-up of harm
reduction programs has been slower than expected,
coverage is still poor, and law enforcement and local
communities still often do not understand the concept
of harm reduction [16]. Although the government con-
tinues to officially oversee the response to the epidemic,
community-based organizations are emerging as import-
ant players in expanding harm reduction programs and
many are building on the empowerment model.
One of these emerging organizations is the Centre for
Supporting Community Development Initiatives (SCDI),
a Vietnamese NGO established in January 2010. SCDI
aims to integrate expertise from a variety of fields includ-
ing medicine, public health, psychology, law, economics,
and education to implement and promote sustainable
social development among marginalized and stigmatized
populations in Vietnam. In collaboration with the Vietnam
Civil Society Partnership Platform on AIDS, SCDI has
supported the development of two community-based
groups (CBGs) with storefronts for drug users in Hanoi.
These CBGs, called The Bullet Point (in the Hai
Ba Trung District) and White Sand (in the Long
Bien District), are largely organized and operated by
current and former drug users. They were established in
2009 and currently receive most of their funding from
SCDI although they raise some of their own funds through
community service activities. The CBGs go beyond
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services and activities including peer education on HIV,
overdose prevention and safe sexual practices, providing
support in detoxification, finding jobs, and accessing syr-
inge exchange and medical care. The Bullet Point is closely
linked with a group of sex workers and the sexual partners
of drug users – forming a coalition named “Coming
Home”. The White Sand is linked with Bright Future
Network – a network of people living with HIV. The
CBGs, which currently have over 500 members between
them, also engage in advocacy in their communities to re-
duce stigma surrounding drug use and HIV. Other drug
user CBGs and organizations are being developed around
Vietnam based on the model these two CBGs provide.
There have been a small number of evaluations of
peer-based programming for drug users in Vietnam, but
more data about such programs are needed in order to
demonstrate the impact of these programs and, if the re-
sults are promising, then serve as advocacy in expanding
harm reduction and empowerment programs for drug
users in Vietnam [3,14,15,18]. This report constitutes one
of the first evaluations for such community-based pro-
grams in the city of Hanoi, and indeed in all of Vietnam. It
adds to the body of knowledge about drug users in Hanoi
by evaluating the impact of the CBGs supported by SCDI
by interviewing members of the CBGs – both current and
former drug users - and their peers who are not members.
We focused on issues of general well-being, HIV, hepatitis,
and overdose prevention knowledge, and interactions with
the drug control system. We hypothesized that the CBGs
would have positive effects on the lives of their members,
and that for measures of quality of life, social support, and
harm reduction-related knowledge, CBG members would
surpass non-members. In addition, among the subset of
members and non-members who were actively injecting at
the time of the interview, we hypothesized that members
would have lower levels of risky injection and greater
access to sterile syringes.
Methods
Sampling
Subjects were recruited from January to December of
2011 in Hai Ba Trung and Long Bien, the two districts
of Hanoi where the CBGs operate. After giving verbal
informed consent, subjects completed a structured survey
given by a trained interviewer from SCDI. The interview
lasted approximately 50 minutes, and subjects were com-
pensated 50,000 VND (about $2.50) for their participation.
This was not an intervention research study, and the
cross sectional nature of the data collection required the
use of a comparison group rather than baseline and
follow-up data for members. Eligibility criteria included
having ever used drugs illicitly, being at least eighteen
years of age, and residing in a neighborhood served byone of the two CBGs. Members were defined as individ-
uals who returned to the CBGs within three months of
their first visit and appeared in the logs of the CBGs. The
logbook recorded the participation of drug users in the
program to detail attendance at CBG activities. When a
drug user first participated, that individual was registered
to the group and his/her information entered in the log.
Because there are both hard copy and electronic records, a
simple search of electronic records was employed to deter-
mine if individuals returned within three months of initial
enrollment. This information was retrieved from the log
and such individuals would be “qualified” as a member.
When members made contact with the center during
the data collection period, they were offered the opportun-
ity to participate in the study. Non-members were drug
users from the same districts of Hanoi who had not had
any contact with the CBGs or had only very recently made
first contact and did not yet re-appear in the CBGs’ logs.
They were accrued through community outreach by SCDI
staff, referrals by members (for which members were com-
pensated 30,000 VND, about $1.50), and referrals by other
non-members who had participated in the study.
Measures
Subjects were interviewed using a structured survey
made up of existing, validated instruments. The survey
assessed demographic information, psychosocial factors,
knowledge regarding HIV, hepatitis, and overdose, expo-
sures to the criminal justice system, and drug-using risk
behaviors to get a full picture of the study population.
The World Health Organization Quality of Life-BREF
(QoL) survey was used to assess self-reported quality of
life, including overall quality of life, overall quality of
health, and physical quality of life (as measured by self-
reported pain, energy, sleep quality, mobility, activities,
and medications), psychological (as measured by self-
reported positive/negative emotions, self-esteem, body
image, and spirituality), social (as measured by self-
reported relationships, support, and sexual activity), and
environmental (as measured by self-reported safety,
home, finances, services, access to information, leisure,
and transportation) domains. All items were measured
using a 5-point Likert scale with higher scores indicating
higher quality, and scoring of the survey was performed in
accordance with the QoL manual [19].
Self-efficacy (self-confidence to perform a specific
behavior/action) and social outcome expectancies (per-
ceptions about others’ reaction to a specific behavior/
action) were adapted from previously reported measures,
and examined self-reported confidence in one’s abilities to
get new syringes, refuse to participate in risky injection
behaviors, access drug treatment and other medical care,
and the perceptions of friends and family about drug use
[20]. Questions assessing subjects’ knowledge regarding
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prevention of overdose and hepatitis infection were adapted
from previously reported assessments and were scored as a
percentage of questions answered correctly [21,22].
Questions about drug-using history and behaviors were
adapted from earlier work in consultation with SCDI staff
to ensure appropriateness to the Vietnamese drug-using
population [23]. Subjects who reported injecting in the last
thirty days were asked about their injection behaviors dur-
ing that time, including frequency of injection, sharing
drugs with others, reusing their own or another person’s
syringes, passing used syringes to others, and injection
hygiene.
The survey instrument was developed in English,
translated to Vietnamese by a team of native Vietnamese
speakers, and subsequently back-translated to ensure no
loss of meaning in translation. It was administered to 53
subjects before a skip pattern was altered, one question
was added, the definition of opioids was clarified, and
then the remainder of the sample was collected.
Data analysis
The outcome was defined as membership in the group,
enabling us to examine multiple demographic, behavioral,
and psychosocial factors that might differ between mem-
bers and non-members of the CBGs. Demographic data
included age, sex, education, and marital status, and where
participants had slept in the last thirty days. Psychosocial
factors were assessed as the mean score of the Likert
scales. Knowledge was assessed as the percentage of true/
false questions answered correctly out of four questions
on sexual transmission of HIV, six questions on hepatitis,
and eleven questions on overdose. Both incorrect and
“Don’t know” responses were counted as wrong. Encoun-
ters with the criminal justice system were generally dichot-
omized as “ever” or “never”, but those who had been sent
to a government detoxification center were asked how
many times, and the mean number of times was reported.
Those who had been to prison were asked if drugs were
the cause of their imprisonment.
The analysis was performed in two stages. First, all
variables were examined in bivariate analyses (t-tests for
continuous variables and Chi-squared tests for categor-
ical variables) for associations between the variable and
member status. To minimize Type II error, all variables
associated at the p < 0.10 level of significance were in-
cluded in a multivariate logistic model with member-
ship status as the dependent variable. The multivariate
logistic regression was performed stepwise with manual
backward selection, and only those variables that were
significant at the p < 0.05 level of significance were in-
cluded in the final model.
Because only a proportion of subjects had injected
drugs in the last thirty days, a sub-analysis of thosesubjects was conducted, examining injection risk behav-
iors (past 30 days) and self-efficacy regarding getting
new syringes and not engaging in risk behaviors. Risky
behaviors were generally dichotomized as “never” or “at
least once”. The number of injections per month, the
proportion of those injections performed with new, un-
used needles, and the proportion of those injections per-
formed alone were reported as means. Bivariate analyses
(t-tests for continuous variables and Chi-squared tests
for categorical variables) were performed to determine
association between injection variables and membership.
Finally, because we were interested in the gaps in
knowledge that exist in the population of drug users in
Hai Ba Trung and Long Bien districts of Hanoi, the pro-
portion of drug users answering each question correctly
was assessed. The percentage of all subjects answering
each knowledge question correctly was determined with
a 95% confidence interval.
Ethical review
Data were collected by SCDI for internal evaluation pur-
poses, and therefore did not undergo review by an ethical
review board. The analysis of de-identified data conducted
in this paper was approved for exemption by the Human
Investigations Committee of Yale University School of
Medicine.
Results
Demographics and participant characteristics
The study recruited 372 current and former drug users
from the Hai Ba Trung and Long Bien districts in Hanoi,
Vietnam. Table 1 summarizes the major demographic
characteristics of the study sample comparing members
and non-members of the CBGs. The two groups did not
differ significantly in age, age of first drug use, sex, educa-
tion, marital status, or the type of lodging in the last thirty
days. The mean age of subjects was 34.2 years, and the
mean age of first drug use was 22.8 years. The majority of
subjects were male (73.9%). Most participants (85.9%) had
completed a middle or high school education. Of the
remaining subjects, 8.1% had completed only elementary
school, and 6.0% had attended any college. Exactly half of
all subjects were married, another 20.4% were separated
or divorced, few were widowed (3.2%), and the remain-
der had never married (26.3%). In the last thirty nights,
nearly all subjects had slept in either their own home or
the home of another (97.2%). The rest (2.8%) had slept
in hospitals/clinics, government centers/prisons, or on the
street.
As shown in Table 2, only two-thirds of the participants
(68%) reported ever injecting drugs, and the number of
injectors did not differ significantly by membership
status. Fewer reported currently injecting (48.5%), and
the proportion currently injecting was higher among
Table 1 Participant sociodemographic characteristicsa
Variable All 372 (100%) Members 188 (50.5%) Non-members 184 (49.5%) P-value
Ageb 34.2 (6.9) 34.7 (6.7) 33.7 (7.2) 0.158
Age of first drug useb 22.8 (5.8) 22.3 (5.8) 23.2 (5.9) 0.110
Male 272 (73.9) 131 (70.8) 141 (77.0) 0.173
Education 0.515
Elementary 30 (8.1) 17 (9.1) 13 (7.1)
Middle 146 (39.5) 69 (36.9) 77 (42.1)
Some High school 66 (17.8) 39 (20.9) 27 (14.8)
High school graduate 106 (28.6) 51 (27.3) 55 (30.0)
Some College or more 22 (6.0) 11(5.9) 11 (6.0)
Marital Status 0.130
Married 186 (50.0) 89 (47.3) 97 (52.7)
Separated/divorced 76 (20.4) 46 (24.5) 30 (16.3)
Widowed 12 (3.2) 8 (4.3) 4 (2.2)
Never Married 98 (26.3) 45 (23.9) 53 (28.8)
Sleep last 30 daysc 0.536
Own or others’ home 353 (97.2) 181 (97.8) 172 (96.6)
Other 10 (2.8) 4 (2.2) 6 (3.4)
aChi-squared test, given as N (column %) unless otherwise noted. Numbers and percentages may not sum to total due to missing data.
bt-test given as mean (standard deviation).
cFisher’s Exact Test, given as N (column %).
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p = 0.044). This is consistent with a significantly higher
proportion of non-members also using opioids in any
form during the past 30 days (57.1% vs. 44.1% of those
ever injecting, p = 0.013).
Bivariate analyses
In the unadjusted bivariate analyses presented in Table 3,
membership was associated with a statistically signifi-
cant increase in all domains of quality of life (p < 0.001
to p = 0.007), self-efficacy to get healthcare (p < 0.001),
and social outcome expectancies with family and friends
(p = 0.002 and p < 0.001, respectively). Overall know-
ledge about HIV and hepatitis was low and did not dif-
fer significantly between members and non-members.
On average, members answered 57.6% of HIV questionsTable 2 Participant drug use
Variable All 372 (100%) Me
Drug Use History
Age of first drug usea 22.8 (5.8)
Have ever injected drugs 236 (68.0)
Current Drug Use
Used opioids in the last 30 days 187 (50.5)
Used amphetamines in the last 30 days 25 (6.9)
Injected in the last 30 daysb 114 (48.5)
at-test given as mean (standard deviation).
bContingent on having ever injected drugs.correctly, and non-members answered 56.2% correctly.
Members answered 57.9% of hepatitis questions correctly,
and non-members answered 54.2% correctly. Although
members, on average, answered a larger percentage of
the overdose knowledge questions correctly than did
non-members (p = 0.007), knowledge of overdose was the
lowest of all, with members answering a mean of only
37.6% of questions correctly and non-members answering
only 33.2% correctly.
Two of the five drug use items differed significantly
between members and non-members. Both of these per-
tained to current use – use of an illicit opioid in any
form in the past 30 days and injection of any drug in the
past 30 days – and the frequency of these behaviors was
lower among members. Neither of the drug use history
items differed between members and non-members.mbers 188 (50.5%) Non-members 184 (49.5%) P-value
22.3 (5.8) 23.2 (5.9) 0.110
118 (66.3) 118 (69.8) 0.481
82 (44.1) 105 (57.1) 0.013
11 (5.9) 14 (7.9) 0.461
51 (42.2) 63 (55.3) 0.044
Table 3 Associations between membership and psychosocial, knowledge, and criminal justice variablesa
Variable
Bivariate analyses Multivariate logistic model
Members 188 (50.5%) Non-members 184 (49.5%) P-value aOR 95% CI P-value
Quality of Life (QOL)b
Overall self-rated QOL 2.8 (0.7) 2.5 (0.7) <0.001
Overall self-rated health 3.0 (0.8) 2.6 (0.8) <0.001
QOL physical 3.1 (0.5) 3.0 (0.4) 0.007
QOL psychological 3.2 (0.5) 2.8 (0.6) <0.001 2.04 1.07-3.93 0.032
QOL social 3.1 (0.6) 2.8 (0.7) <0.001
QOL environmental 2.8 (0.6) 2.4 (0.5) <0.001 2.54 1.31-4.93 0.006
Self Efficacy/Social Outcome Expectancyc
Self-efficacy to get healthcare 2.7 (0.9) 2.1 (1.0) <0.001 1.59 1.24-2.04 <0.001
Social Outcome Expectancy (family) 2.5 (1.2) 2.1 (1.1) 0.002
Social Outcome Expectancy (friends) 2.6 (1.1) 2.2 (1.0) <0.001
Knowledged
HIV knowledge 57.6 (25.2) 56.2 (24.7) 0.607
Hepatitis knowledge 57.9 (24.4) 54.2 (23.6) 0.145
Overdose knowledge 37.6 (16.7) 33.2 (14.6) 0.007
Drug Use, past 30 days
Opioid Use 82 (44.1) 105 (57.1) 0.013
Injection of Drugs 51 (27.1) 63 (34.2) 0.044
Policing/Incarceration
Ever Had Interactions with Police about Drugse 147 (81.2) 123 (66.9) 0.002 3.15 1.79-5.52 <0.001
Ever in a Government Centree 118 (65.2) 94 (52.8) 0.017
No. Times in Government Centre (if ever) 1.4 (0.8) 1.5 (0.9) 0.912
Ever sent to prisone 76 (41.8) 60 (32.6) 0.070
Prison was about drug use (if ever in prison)e 61 (84.7) 46 (76.7) 0.239
at-test given as mean (standard deviation), unless otherwise noted. Numbers and percentages may not sum to total due to missing data.
bResponses for Likert scores 1–5 (Very poor, Poor, Neither poor nor good, Good, Very Good).
cResponses for Likert scores 1–5 (No confidence at all, Not very confident, Neither confident nor not confident, Somewhat confident, Totally confident).
dPercent of questions answered correctly (standard deviation).
eChi-squared test given as N (column %).
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than non-members (81.2% vs. 66.9%) had ever interacted
with the police (i.e., arrests, questioning, urine testing,
home visits) concerning drug-related activities (p = 0.002).
A larger proportion of members (65.2%) than non-
members (65.2% vs. 52.8%) had ever been in a government
detoxification center (p = 0.017), but among those who
had been sent to such a center, the average number of
times sent did not differ between the two groups. Substan-
tially more members than non-members (41.8% vs. 32.6%)
had been in prison (p = 0.070), but a similar proportion of
imprisonments were for reasons related to drugs.
Multivariate model
In the multivariate model presented in Table 3, only
four variables remained significantly associated with
membership status. Reporting higher scores on psycho-
logical and environmental domains of the QoL wasassociated with membership in the CBGs (OR 2.04, 95%
CI 1.07-3.93 and 2.54, 95% CI 1.31-4.93, respectively).
Members also differed from non-members by their
higher reported self-efficacy for getting drug-related
healthcare (OR 1.59, 95% CI 1.24-2.04). Finally, self-
reported police interaction involving drugs was the only
criminal justice-related variable that remained signifi-
cantly associated with membership (OR 3.15, 95% CI
1.79-5.52) in the multivariate model.
Gaps in knowledge
Table 4 presents the knowledge items in the instrument
and the percentages of respondents answering each
question correctly. Given the lack of differences in
knowledge scores, members and non-members were ag-
gregated for this analysis. The proportion of subjects
answering each HIV question correctly ranged from
45.2% (95% CI 40.1-50.3) to 66.9% (62.1-71.8). Hepatitis
Table 4 Percentage of respondents answering knowledge questions correctly
True/False item Correct answer % correct* True/False item Correct
answer
% correct*
HIV/AIDS KNOWLEDGE OVERDOSE KNOWLEDGE
When a couple decides that they are
ONLY going to have sex with each other,
they no longer need to use condoms to
prevent HIV.
F 66.9 (62.1, 71.8) Causing physical pain will help keep
someone who is overdosing conscious or
alive.
F 36.9 (31.9, 41.9)
The fewer sex partners you have in your
life, the less likely you are to get HIV.
T 66.0 (61.2, 70.9) Fatal ODs are more likely to happen
when people use alone.
T 89.5 (86.4, 92.6)
People can still transmit the HIV/AIDS
virus even if they test negative for the
virus.
T 45.2 (40.1, 50.3) People are more likely to have an OD if
they use soon after getting out of a
government center, prison, or
detoxification program.
T 84.8 (81.1, 88.5)
Most people who have HIV know they
have it.
F 52.1 (46.9, 57.2) Most heroin OD deaths happen very
quickly, in less than 15 minutes after
taking the drugs.
F 9.8 (6.7, 12.8)
HEPATITIS KNOWLEDGE It is easy to tell the difference between
a “heavy nod” and a heroin overdose.
F 10.1 (7.0, 13.2)
Hepatitis can cause liver cancer. T 72.1 (67.5, 76.7) Sweating and anxiety are signs of a
heroin OD.
F 58.0 (52.9, 63.1)
HIV is easier to transmit than hepatitis. F 46.4 (41.3,51.6) Injecting water can slow or reverse the
effects of an opioid overdose
F 30.5 (25.7, 35.2)
You will be able to recognize if any
individual is infected with hepatitis.
F 40.9 (35.8, 46.0) Someone who is overdosing should be
immediately placed on their back.
F 18.3 (14.3, 22.3)
Most people infected with hepatitis know
that they have the disease.
F 46.4 (41.2, 51.6) Naloxone is a medication for reversing
the effects of a heroin OD.
T 47.7 (42.4, 53.0)
Drinking alcohol worsens the course of
hepatitis C.
T 84.2 (80.4, 87.9) Naloxone must be injected into a vein. F 26.9 (22.2, 31.7)
You are more likely to get hepatitis B than
hepatitis C by having unprotected sex.
T 54.3 (49.1, 49.4) Naloxone will reverse a stimulant
overdose.
F 24.8 (20.3, 29.4)
*Mean and 95% confidence interval.
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(35.8-46.0) to as high as 84.2% (80.4-87.9) answering
each question correctly. Knowledge of overdose was the
most varied, with the proportion of correct answers per
question ranging from just 9.8% (6.7-12.8) to as high as
89.5% (86.4-92.6).
Sub-analysis of current injection drug users
Only 114 study participants had injected drugs within
30 days of the time of interview. The difference in percent-
ages between members and non-members (27.1% and
34.2%, respectively) was not significant. Table 5 presents
the bivariate analyses for variables regarding injection
practices and injection-related self-efficacies. Members
and non-members did not differ significantly for most of
the behaviors assessed. However, without controlling for
other variables, members were slightly older (p = 0.029),
reported a larger proportion of injections with new nee-
dles (1.0 compared to 0.9, p = 0.036), and reported higher
self-efficacy for getting new syringes (p = 0.004), refusing
to share syringes (p = 0.006), and for not sharing water
when injecting (p = 0.086). The sample size of active injec-
tors was considered too small to conduct a multivariateanalysis for the injection-related variables but suggests
that additional research is needed to confirm and refine
the findings from the small subsample of active injectors.
Discussion
The goal of this study was to determine the characteristics,
psychosocial factors, and behaviors that differ between
members of the two CBGs - The Bullet Point and White
Sand - and drug users in the same districts of Hanoi who
are not members and to test several hypotheses about the
differences that membership in a CBG might produce.
This report is focused on three hypotheses: (1) that CBG
membership would have positive effects on the lives of
their members, (2) that knowledge regarding syringe-
transmitted infections (HIV and hepatitis) and drug over-
dose would be higher among members, and (3) that
among active injectors, members would have lower levels
within the 30 days prior to interview of risky injection
practices and greater access to sterile syringes. The first
and third hypotheses were confirmed while the second
was not, although more data collection from active injec-
tors (CBG members and non-members alike) is needed to
strengthen our analysis of the effect of membership.
Table 5 Associations between membership and
psychosocial factors and injection risk behaviors in a




N = 63 P-value
Age 35.2 (6.5) 32.6 (6.1) 0.029
Age at first injection 24.9 (5.3) 24.3 (5.3) 0.560
Injections/month 49.0 (42.1) 49.4 (35.4) 0.948
Proportion of Injections with new
needle
1.0 (0.1) 0.9 (0.2) 0.036
Proportion of Injections Alone 0.8 (0.3) 0.8 (0.3) 0.668
Split drugsb 19 (37.2) 31 (49.2) 0.201
Reused syringesc,d 3 (6.0) 7 (11.5) 0.507
Passed syringes to othersc,d 1 (2.1) 4 (6.6) 0.382
Cleaned skind 0.201
Never 28 (57.1) 42 (67.7)
At least once 17 (34.7) 19 (30.6)
Many times 4 (8.2) 1 (1.6)
How Cleaned Skinc 0.101
Water 12 (52.2) 6 (31.6)
Sponge/Alcohol Towel 4 (17.4) 4 (21.0)
Anti-bacterial liquid 2 (8.7) 1 (5.3)
Tongue/saliva 2 (8.7) 5 (26.3)
Usually nothing 3 (13.0) 0 (0.0)
Other 0 (0.0) 3 (15.8)
How Stopped Bleedingc 0.127
Cotton/sponge 18 (39.1) 13 (22.4)
Tissue 9 (19.6) 17 (29.3)
Alcohol sponge 5 (10.9) 2 (3.4)
Fingers 13 (28.3) 22 (37.9)
Other 1 (2.2) 5 (6.9)
Self-Efficacye
Get new syringes 3.8 (0.3) 3.4 (0.8) 0.004
Refuse to share syringes 3.5 (0.7) 3.1 (0.8) 0.006
Not share water 3.0 (1.1) 2.6 (1.2) 0.086
Bold p-values indicated variables that remained significant in the
multivariate model.
at-test given as mean (standard deviation) unless otherwise noted. Numbers
and percentages may not sum to total due to missing data.
bChi-squared test given as N (column %).
cFisher’s Exact test given as N (column %).
dDichotomized to Never/At Least Once, with At Least Once presented.
eMean responses from Likert Score 1–5 (No confidence at all, Not very
confident, Neither confident nor not confident, Somewhat confident,
Totally confident).
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non-members provide a picture of drug users in Hai
Ba Trung and Long Bien that is generally consistent with
earlier reports. The proportion of male drug user sub-
jects (73.9%) is somewhat lower than in other studies,
which have reported male/female ratios of 9:1 to 19:1[5,24-26]. This may reflect one of three non-exclusive
influences on participant recruitment: the reported in-
creasing proportion of female drug users in Vietnam [5],
an assumption of drug using to be a male phenomenon
that limited other data collection efforts to recruit fe-
male drug users, or the heightened stigma experienced
by female drug users that led them to hide their behaviors
[27]. The lack of statistical differences in demographics be-
tween members and non-members provides evidence that
members were similar to non-members prior to joining
the CBGs. This in turn supports the hypothesis that differ-
ences observed in psychosocial and behavioral factors may
be linked to participation in the activities of the CBGs al-
though it was not possible to determine if these activities
produced the difference.
The higher scores in the QoL psychological domain
reported by members compared to non-members are
important and encouraging. Several studies have shown
a correlation between opioid substitution therapy and
increased psychological QoL [28,29], and this study sug-
gests that the CBGs under study may have a similar im-
pact. In a country where only 1.3% of IDUs receive
substitution therapy [17,30], CBGs may extend the
reach of these mental health benefits to larger numbers
drug users. Additionally, improved psychological QoL
has been associated with reduced injection risk behav-
iors [31], which in turn affects transmission of HIV and
hepatitis, suggesting that the benefits of the CBGs could
spread beyond the psychological realm into physical
health outcomes. However, we cannot rule out other
explanations for the difference between members and
non-members, including unknown factors such as pres-
ence of co-morbidities like depression and HIV infection,
and employment status.
The reported higher self-efficacy among members in
getting healthcare related to drug use (community
based-treatment, substitution therapy, and medical care
for problems related to drug use) has several possible
explanations. First, because the CBGs offer referrals to
healthcare, it is possible that the increased self-efficacy
in members is due to already having successfully
received a referral to drug-related healthcare [20]. Con-
versely, lower self-efficacy in non-members may result
from their concerns about vulnerability to disclosure-
related stigma from families and communities [28,32,33],
perceptions of law enforcement activity [34], or disclos-
ure of HIV status [35]. Membership in visible commu-
nity groups such as the CBGs may mitigate these
concerns. More research is needed to determine what
other factors, both individual and environmental, are
associated with increased self-efficacy to get healthcare.
Because self-efficacy can be an important predictor of
behavior [20,36,37], future interventions should aim to
target those factors.
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interactions with the police can be explained by several
non-exclusive factors. First, The Bullet Point and White
Sand were able to conduct outreach at the 06 centers
shortly after the CBGs opened, meaning that many of
the members were recruited from a population where
100% of individuals had a history of interaction with the
police. Second, drug users who have had an interaction
with the police are more likely to be disclosed as drug
users to friends and family as a result of this interaction.
Conversely, undisclosed individuals risk revealing their
drug user status to police and other community members
by joining the CBGs; this may result in a reluctance to join
among those who have not already had an interaction with
police (Pham Thi Minh, personal communication, May 8,
2012). Finally, it is possible that because of more know-
ledge about the advocacy efforts of the CBGs, members
felt more comfortable reporting interactions with the
police to interviewers. The literature is conflicting as
to whether police interference with community-based
harm reduction efforts remains a problem [18,34]. More
in-depth research is needed to understand the important
role that law enforcement plays in the successes of and
challenges faced by the CBGs under study.
Perhaps the most important finding was that the qual-
ity of life reported by subjects was also independently
higher in members than in non-members for both the
QoL environmental and psychological subscales. Rhodes
and others have written about the “risk environment”, a
construct encompassing factors exogenous to the indi-
vidual, as a significant predictor of HIV prevalence and
behavior change [38,39]. Our data indicate that the risk
environment is lessened for members, which would sug-
gest that the CBGs benefits might operate at a structural
level. Although harm reduction programs often focus on
individual factors like knowledge and changing individual
behavior [40], their activities also work at the structural
level to reduce negative consequences of drug abuse
[22,41,42]. Advocacy efforts of the CBGs with law en-
forcement may allow members to feel more comfortable
in their surroundings [43,44]. Members may also ex-
perience greater environmental security through factors
not measured directly, including employment or HIV
infection. Though some of these factors are likely af-
fected by membership, greater environmental security
may have made individuals more likely to join their
CBG in the first place. Given the potential implications
of improved environmental QoL on health outcomes,
more research is needed on cause and effect in the rela-
tionship between membership and environmental QoL.
Both members and non-members had disappointingly
low knowledge about HIV, hepatitis, and overdose. The
reality may be worse than the raw scores indicated be-
cause the proportion of subjects answering a true/falsequestion correctly usually overestimates the actual num-
ber who know the correct response – those knowing the
answer provide it; those not knowing it may guess it [45].
Questions on HIV and hepatitis centered mainly on know-
ledge of sexual transmission due to concerns about gener-
alized epidemics. While no clear trends emerged in HIV
knowledge, no question was answered correctly by more
than two-thirds of subjects. More subjects correctly an-
swered questions about the course of virally-induced
hepatic disease than questions about transmission and
disease recognition. Given the already high rates of sex-
ual transmission of HIV and hepatitis B in Vietnam, the
low knowledge on sexual transmission is particularly
concerning. More respondents were able to assess when
an opioid overdose is likely to occur than were able to
recognize its physical manifestations or how to manage
one when it happens. While knowing when overdoses
are likely to occur is important in preventing any overdose,
poorly managed overdoses are a cause of unnecessary mor-
tality and morbidity [46,47]. More overdose education ef-
forts are needed to prevent and respond appropriately to
them. More broadly, because behavior change is dependent
upon knowledge, motivation, and necessary skills [48], im-
proving knowledge about disease transmission through sex
and overdose recognition and management should be pri-
orities for the CBGs and all groups doing harm reduction
in Hanoi and such efforts should be coupled with motiv-
ational and practical skills building training.
In the sub-analysis of IDUs, the frequencies of risk
behaviors in both members and non-members were
lower than in some recent reports [49,50]. While this
could indicate a positive trend in injection practices, it
could also be a result of reporting bias given the highly
stigmatized nature of the behaviors under study or dif-
ferences between our convenience sample and others
previously accrued. Additionally, the small numbers of
individuals reporting injection in the last thirty days,
while a positive observation with respect to health out-
comes, significantly reduced the power to determine
differences between members and non-members. Des-
pite statistically significant differences in the bivariate
analyses in the proportion of injections performed with
a new needle and a variety of risk reduction-related
self-efficacy measures, the sample size was too small to
conduct a multivariate analysis. Work with a larger
sample size might provide more definitive evidence re-
garding the association between injection risk behaviors,
self-efficacy, and membership in the CBGs under study.
This study is not without limitations. First and foremost,
the cross-sectional nature of the study made it impossible
to posit causal relationships between membership in the
CBGs and differences in variables studied. Despite subjects
being similar across all demographic variables examined,
it is possible that additional and unknown factors or
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examined. There is no way of knowing if the differences
we observed between groups of members and non-
members existed before members joined their CBG.
Second, the sampling was not done at random, although
several reports have indicated that snowball sampling
can yield relatively representative samples of hidden
populations [51]. However, our results may not be
generalizable to drug-using populations outside of Hanoi.
Third, many of the behaviors reported on are considered
socially undesirable, and our reliance on self-report in
face-to-face interviews may result in under-reporting of all
behaviors, and of the riskiest behaviors in particular.
Fourth, serological data confirming HIV and hepatitis B
and C infection status were not collected. Although these
data were not a direct interest in this study, it has been
shown that HIV status can alter subject responses about
self-efficacy and risk behaviors [29,35]. Additionally, it
has been reported that injection risk behaviors may dif-
fer between HIV-infected and non-infected individuals
in Vietnam, with HIV-positive individuals more willing
to receive borrowed needles and share with other infected
users [52]. Finally, there were challenges in measuring the
degree of participation in the CBGs by those individuals
we have characterized as members. Two CBGs were stud-
ied, and although they have largely identical structures,
services, and programming, we were not able to analyze
the CBGs separately to determine if characteristics and be-
haviors of members differed between the CBGs. Intensity
of participation in the CBGs was also difficult to quantify
but may provide important information in explaining the
impact of the groups.
Looking forward, there are several possible avenues of
research to pursue. A cohort study with longitudinal
data would help to affirm a causal relationship between
group membership and the variables studied here. Infor-
mation on HIV and hepatitis B and C serologies and inci-
dence could also be included, as slowing those epidemics
is an important goal of harm reduction efforts. As previ-
ously mentioned, a larger sample size of active IDUs
would give a clearer picture of the differences in risk be-
haviors between members and non-members. Finally, this
study does not answer questions about stigma associated
with drug use, and an evaluation of the effect of the ad-
vocacy efforts of the CBGs is needed. Such a study is in
progress and will be reported once completed.
In conclusion, although there seem to be real and
independent differences between members and non-
members of The Bullet Point and White Sand groups
across a variety of important psychosocial factors, the
low knowledge regarding HIV, hepatitis, and overdose
among non-members and members alike suggests room
for improvement in the education components of the
programming offered by the CBGs. Consistent withseveral theories of behavior change, the increased self-
efficacy and quality of life (which seems to be present in
members of the CBGs) can be combined with improved
knowledge about risks and skills for negotiating those risks
to provide services that might enhance the prevention of
adverse outcomes like syringe-borne viral infections and
overdose in drug users in Hanoi [35,38,48,53].
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